Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

Jonggun Kim, Hyung Kwan Kim, Sae Hun Kim, Ji Young Imm, Kwang Youn Whang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Milk is known as a safe food and contains easily absorbable minerals and proteins, including whey protein, which has demonstrated antiosteoporotic effects on ovariectomized rats. This study evaluated the antiosteoporotic effect of whey protein concentrate hydrolysate (WPCH) digested with fungal protease and whey protein concentrate (WPC). Two experiments were conducted to determine (1) efficacy of WPCH and WPC and (2) dose-dependent impact of WPCH in ovariectomized rats (10 weeks old). In Experiment I, ovariectomized rats (n=45) were allotted into three dietary treatments of 10 g/kg diet of WPC, 10 g/kg diet of WPCH, and a control diet. In Experiment II, ovariectomized rats (n=60) were fed four different diets (0, 10, 20, and 40 g/kg of WPCH). In both experiments, sham-operated rats (n=15) were also fed a control diet containing the same amount of amino acids and minerals as dietary treatments. After 6 weeks, dietary WPCH prevented loss of bone, physical properties, mineral density, and mineral content, and improved breaking strength of femurs, with similar effect to WPC. The bone resorption enzyme activity (tartrate resistance acid phosphatase) in tibia epiphysis decreased in response to WPCH supplementation, while bone formation enzyme activity (alkaline phosphatase) was unaffected by ovariectomy and dietary treatment. Bone properties and strength increased as the dietary WPCH level increased (10 and 20 g/kg), but there was no difference between the 20 and 40 g/kg treatment. WPCH and WPC supplementation ameliorated bone loss induced by ovariectomy in rats.

Original languageEnglish
Pages (from-to)1349-1356
Number of pages8
JournalJournal of Medicinal Food
Volume18
Issue number12
DOIs
Publication statusPublished - 2015 Dec 1

Fingerprint

Protein Hydrolysates
Bone and Bones
Minerals
Diet
Dietary Proteins
Whey Proteins
Ovariectomy
Epiphyses
Fungal Proteins
Enzymes
Bone Resorption
Acid Phosphatase
Tibia

Keywords

  • Bone physical properties
  • Bone strength
  • Osteoporosis
  • Ovariectomy
  • Whey protein hydrolysate

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats. / Kim, Jonggun; Kim, Hyung Kwan; Kim, Sae Hun; Imm, Ji Young; Whang, Kwang Youn.

In: Journal of Medicinal Food, Vol. 18, No. 12, 01.12.2015, p. 1349-1356.

Research output: Contribution to journalArticle

Kim, Jonggun ; Kim, Hyung Kwan ; Kim, Sae Hun ; Imm, Ji Young ; Whang, Kwang Youn. / Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats. In: Journal of Medicinal Food. 2015 ; Vol. 18, No. 12. pp. 1349-1356.
@article{4f63a57358c24ed7bdf2f885edf6c878,
title = "Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats",
abstract = "Milk is known as a safe food and contains easily absorbable minerals and proteins, including whey protein, which has demonstrated antiosteoporotic effects on ovariectomized rats. This study evaluated the antiosteoporotic effect of whey protein concentrate hydrolysate (WPCH) digested with fungal protease and whey protein concentrate (WPC). Two experiments were conducted to determine (1) efficacy of WPCH and WPC and (2) dose-dependent impact of WPCH in ovariectomized rats (10 weeks old). In Experiment I, ovariectomized rats (n=45) were allotted into three dietary treatments of 10 g/kg diet of WPC, 10 g/kg diet of WPCH, and a control diet. In Experiment II, ovariectomized rats (n=60) were fed four different diets (0, 10, 20, and 40 g/kg of WPCH). In both experiments, sham-operated rats (n=15) were also fed a control diet containing the same amount of amino acids and minerals as dietary treatments. After 6 weeks, dietary WPCH prevented loss of bone, physical properties, mineral density, and mineral content, and improved breaking strength of femurs, with similar effect to WPC. The bone resorption enzyme activity (tartrate resistance acid phosphatase) in tibia epiphysis decreased in response to WPCH supplementation, while bone formation enzyme activity (alkaline phosphatase) was unaffected by ovariectomy and dietary treatment. Bone properties and strength increased as the dietary WPCH level increased (10 and 20 g/kg), but there was no difference between the 20 and 40 g/kg treatment. WPCH and WPC supplementation ameliorated bone loss induced by ovariectomy in rats.",
keywords = "Bone physical properties, Bone strength, Osteoporosis, Ovariectomy, Whey protein hydrolysate",
author = "Jonggun Kim and Kim, {Hyung Kwan} and Kim, {Sae Hun} and Imm, {Ji Young} and Whang, {Kwang Youn}",
year = "2015",
month = "12",
day = "1",
doi = "10.1089/jmf.2015.3441",
language = "English",
volume = "18",
pages = "1349--1356",
journal = "Journal of Medicinal Food",
issn = "1096-620X",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

AU - Kim, Jonggun

AU - Kim, Hyung Kwan

AU - Kim, Sae Hun

AU - Imm, Ji Young

AU - Whang, Kwang Youn

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Milk is known as a safe food and contains easily absorbable minerals and proteins, including whey protein, which has demonstrated antiosteoporotic effects on ovariectomized rats. This study evaluated the antiosteoporotic effect of whey protein concentrate hydrolysate (WPCH) digested with fungal protease and whey protein concentrate (WPC). Two experiments were conducted to determine (1) efficacy of WPCH and WPC and (2) dose-dependent impact of WPCH in ovariectomized rats (10 weeks old). In Experiment I, ovariectomized rats (n=45) were allotted into three dietary treatments of 10 g/kg diet of WPC, 10 g/kg diet of WPCH, and a control diet. In Experiment II, ovariectomized rats (n=60) were fed four different diets (0, 10, 20, and 40 g/kg of WPCH). In both experiments, sham-operated rats (n=15) were also fed a control diet containing the same amount of amino acids and minerals as dietary treatments. After 6 weeks, dietary WPCH prevented loss of bone, physical properties, mineral density, and mineral content, and improved breaking strength of femurs, with similar effect to WPC. The bone resorption enzyme activity (tartrate resistance acid phosphatase) in tibia epiphysis decreased in response to WPCH supplementation, while bone formation enzyme activity (alkaline phosphatase) was unaffected by ovariectomy and dietary treatment. Bone properties and strength increased as the dietary WPCH level increased (10 and 20 g/kg), but there was no difference between the 20 and 40 g/kg treatment. WPCH and WPC supplementation ameliorated bone loss induced by ovariectomy in rats.

AB - Milk is known as a safe food and contains easily absorbable minerals and proteins, including whey protein, which has demonstrated antiosteoporotic effects on ovariectomized rats. This study evaluated the antiosteoporotic effect of whey protein concentrate hydrolysate (WPCH) digested with fungal protease and whey protein concentrate (WPC). Two experiments were conducted to determine (1) efficacy of WPCH and WPC and (2) dose-dependent impact of WPCH in ovariectomized rats (10 weeks old). In Experiment I, ovariectomized rats (n=45) were allotted into three dietary treatments of 10 g/kg diet of WPC, 10 g/kg diet of WPCH, and a control diet. In Experiment II, ovariectomized rats (n=60) were fed four different diets (0, 10, 20, and 40 g/kg of WPCH). In both experiments, sham-operated rats (n=15) were also fed a control diet containing the same amount of amino acids and minerals as dietary treatments. After 6 weeks, dietary WPCH prevented loss of bone, physical properties, mineral density, and mineral content, and improved breaking strength of femurs, with similar effect to WPC. The bone resorption enzyme activity (tartrate resistance acid phosphatase) in tibia epiphysis decreased in response to WPCH supplementation, while bone formation enzyme activity (alkaline phosphatase) was unaffected by ovariectomy and dietary treatment. Bone properties and strength increased as the dietary WPCH level increased (10 and 20 g/kg), but there was no difference between the 20 and 40 g/kg treatment. WPCH and WPC supplementation ameliorated bone loss induced by ovariectomy in rats.

KW - Bone physical properties

KW - Bone strength

KW - Osteoporosis

KW - Ovariectomy

KW - Whey protein hydrolysate

UR - http://www.scopus.com/inward/record.url?scp=84952660674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952660674&partnerID=8YFLogxK

U2 - 10.1089/jmf.2015.3441

DO - 10.1089/jmf.2015.3441

M3 - Article

C2 - 26367331

AN - SCOPUS:84952660674

VL - 18

SP - 1349

EP - 1356

JO - Journal of Medicinal Food

JF - Journal of Medicinal Food

SN - 1096-620X

IS - 12

ER -